Previous research has shown that FoxG1 regulates the cell cycle in AD, including (1) by preventing cells from reentering the cell cycle (G0 → G1) through the inhibition of p21-activated kinase (PAK3), and (2) reducing the expression of cell cycle markers, thereby controlling cell cycle progression (Wang et al. 2022b). Here, PAK3 is linked to Alzheimer disease.